Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
E.M. Ciruelos1, P. Villagrasa2, A.M. Antunes De Melo e Oliveira3, S. Pernas Simon4, J. Cortés5, S. Vazquez6, N. Martínez7, A. Perelló8, B. Bermejo De Las Heras9, E. Martínez10, I. Garau Llinas11, M. Mele Olive12, A. Montaño13, E. Vega14, B. Cantos15, M.J. Echarri16, T. Pascual17, P. Celiz18, X. González-Farré19, A. Prat17
Communication in congress
Results poster
ESMO BREAST
2020
